Quantitative Sandwich Enzyme Immunoassay (EIA)
MiraVista
Mira Vista
FBMO
Blastomycosis
Varies
Question ID | Description | Answers |
---|---|---|
Z5523 | Specimen Type |
Submit only one of the following:
Specimen Type: CSF or Bronchoalveolar Fluid
Container/Tube: Sterile leak-proof container
Specimen Volume: 2 mL
Collection Instructions:
CSF: Collect 2 mL of spinal fluid (CSF) in sterile leak-proof container. Send refrigerated in a plastic screw cap vial.
Bronchoalveolar Lavage: Collect 2 mL in sterile leak-proof container. Send refrigerated in a plastic screw cap vial.
NOTE:
1. Specimen type is required.
2. Separate order required for each specimen.
3. Sputolysin, sodium hydroxide, and potassium hydroxide treatment degrade the analyte detected in the assay.
CSF: 0.8 mL; BAL: 0.5 mL
Other | Specimen that is too viscous to pipette. Tissue, biopsy, sputum, bronchial brush, tracheal aspirate, FNA, bone marrow aspirate, stool or samples in transport media, fixative or Isolator tubes |
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Refrigerated (preferred) | 14 days | |
Ambient | 14 days | ||
Frozen |
Reference Value: None Detected
Results reported as ng/mL in 0.2 - 14.7 ng/mL range
Results above the limit of detection but below 0.2 ng/mL are reported as 'Positive, Below the Limit of Quantification'
Results above 14.7 ng/mL are reported as 'Positive, Above the Limit of Quantification'
Cross-reactions are seen with histoplasmosis, paracoccidioidomycosis, penicilliosis, less frequently in coccidiooidomycosis, rarely in aspergillosis and possibly sporotrichosis.
Sputolysin, sodium hydroxide, and potassium hydroxide treatment degrade the analyte detected in the assay.
Monday through Friday
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
87449
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
FBMO | MVista Blastomyces Ag, Fluid | Not Provided |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
Z5523 | Specimen Type | 31208-2 |
Z5524 | Result: | Not Provided |
Z5525 | Interpretation | Not Provided |
Change Type | Effective Date |
---|---|
Test Changes - Specimen Information | 2023-03-07 |
Test Changes - Referral Fee | 2022-12-01 |
Test Changes - Referral Fee | 2022-09-21 |
Test Changes - Referral Fee | 2022-07-01 |